The object
David Devos co-developed a Parkinson's treatment system with a pump implanted under the abdominal skin and a fine catheter that delivers stable dopamine into the brain. The system targets severe motor complications; a 2025 clinical trial reports its intracerebroventricular dopamine delivery and Devos's continuing authorship.
01
What David did
Co-developed an implanted dosing-pump and catheter system that continuously delivers anaerobic dopamine to the brain.
02
Why it matters
The delivery hardware addresses dopamine oxidation and aims to provide continuous brain dosing rather than intermittent oral treatment.
03
Living-status check
Devos co-authored the system's Nature Medicine clinical-trial report published January 7, 2025, and received a 2025 French Academy of Medicine award.